Sign in to fuzzto save your conversations, follow your research and come back anytime.
Vaidya Sane Ayurved Laboratories
SectorHealthcare
| Metric (₹ crore) | Q2 FY23 | Q1 FY24 | Q2 FY24 |
|---|---|---|---|
| Sales | 9,916.89 | 4,558.72 | 5,110.05 |
| Expenses | 9,131.2 | 4,141.58 | 4,841.73 |
| EBITDA | 785.69 | 417.14 | 268.32 |
| Depreciation | 259.79 | 115.53 | 158.65 |
| EBIT | 525.9 | 301.61 | 109.67 |
| Interest | 18.75 | 11.3 | 16.05 |
| Profit Before Tax | 507.15 | 290.31 | 93.62 |
| Net Profit | 966.53 | 246.5 | 235.32 |
| EPS | 4.6 | 2.6 | 1.12 |
| Metric (₹ crore) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Operating Cash Flow | 0.06 | -1.26 | 10.6 |
| Investing Cash Flow | 0.52 | -12.99 | -10.08 |
| Financing Cash Flow | -1.38 | 14.86 | -0.54 |
| Net Cash Flow | -0.8 | 0.61 | -0.02 |
| Metric (₹ crore) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Equity / Shareholders' Funds | 40.45 | 55.6 | 62.54 |
| Total Liabilities | 14.43 | 14.11 | 14.17 |
| Total Assets | 54.88 | 69.71 | 76.71 |